TeklaLife Sciences Investors (HQL) Financials

$19.86

$0.10 (0.51%)

As on 14-Sep-2026 16:00EDT

Market cap

$619 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

3.1

P/B Ratio

1.1

Div. Yield

9.4 %

Annual
Quarterly

Income Statement ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Operating Revenue	86.39	86.69	23.52	-103.25	65.69	124.08
Cost of Revenue	4.97	5.36	5.24	5.55	5.60	4.78
Gross Profit	86.39	86.69	23.52	-103.25	65.69	124.08
Operating Expenses	0.79	1.39	1.17	1.35	1.16	1.03
Operating Profit (EBIT)	85.59	85.30	22.35	-104.60	64.53	123.05
Other Income	--	--	--	--	--	--
Profit before Tax	85.59	85.30	22.35	-104.60	64.53	123.05
Provision for Tax	--	--	22.35	-2.99	-4.15	-2.13
Profit after Tax (Net Income)	85.59	85.30	22.35	-104.60	64.53	123.05
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-104.60	64.53	123.05

Liabilities ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Shareholder's Funds	513.66	459.69	401.93	397.90	523.44	483.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.01	0.89	0.67	11.72	10.75	0.01
Current Liabilities	0.72	0.89	--	5.10	10.75	0.58
Total Liabilities	515.38	460.58	402.60	414.73	534.19	484.17

Assets ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Non-Current Assets	514.13	474.20	397.53	414.08	534.01	483.97
Current Assets	1.25	0.28	5.05	0.62	0.14	0.07
Total Assets	515.38	460.58	402.60	414.73	534.19	484.17
Total Debt*	--	--	--	11.09	1.34	0.03
Net Current Assets	--	--	--	--	--	--

Cashflow ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Cash From Operating Activities	-2.32	--	--	--	0.00	--
Cash Flow from Investing Activities	25.21	--	--	--	--	--
Cash from Financing Activities	-31.63	--	--	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Adjusted EPS ($)	2.96	2.96	0.83	-4.07	2.62	5.18
Cash EPS ($)	2.96	2.96	0.83	-4.07	2.62	5.18
Adjusted Book Value ($)	17.79	15.98	15.00	15.49	21.22	20.36
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.08	--	--	--	--	--
Free Cash Flow per Share ($)	-0.08	--	--	--	--	--

Profitability Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
ROCE (%)	17.59	19.80	5.51	-22.40	12.80	28.38
ROE (%)	17.59	19.80	5.59	-22.71	12.82	28.38
ROA (%)	17.54	19.76	5.47	-22.05	12.67	28.25
EBIT Margin (%)	--	98.40	95.02	101.31	98.24	99.17
Net Margin (%)	99.08	98.40	95.02	101.31	98.24	99.17
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Revenue Growth (%)	0.00	2.69	1.23	-2.57	-0.47	2.79
EBIT Growth (%)	--	281.60	121.37	-262.10	-47.56	274.60
Net Profit Growth (%)	0.35	281.60	121.37	-262.10	-47.56	274.60
EPS Growth (%)	0.00	2.55	1.20	-2.56	-0.50	2.74
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Price / Earnings	5.23	5.09	14.95	-3.35	7.95	3.39
Price / Book Value	0.87	0.94	0.83	0.88	0.98	0.86
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	5.23	4.78	14.26	-3.14	7.71	3.39
Close Price ($)	15.51	15.08	12.47	13.66	20.80	17.58
High Price ($)	15.51	15.90	15.30	21.64	22.70	19.28
Low Price ($)	10.55	11.34	12.25	13.03	16.60	11.45
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debt to Equity	--	--	--	0.03	0.00	0.00
Short term debt to equity ratio	--	--	--	0.03	0.02	0.00
Current Ratio	1.74	0.32	--	0.12	0.01	0.13
Quick Ratio	--	--	--	-6.46	-1.60	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debtors to sales (%)	1.32	0.27	21.44	-0.60	0.23	0.06
Asset Turnover	0.18	0.20	0.06	-0.22	0.13	0.28
Receivable days	2.89	11.11	44.00	-1.37	0.62	6.53
Inventory Days	--	1,383.15	1,875.53	1,674.70	1,128.92	1,338.01
Payable days	26.55	0.12	355.20	172.79	9.80	215.85
Cash Conversion Cycle	--	1,394.14	1,564.34	1,500.55	1,119.74	1,128.69